Company
Nuvectis Pharma, Inc. (NVCT)
Standardized SEC financial data for Nuvectis Pharma, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001875558 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-156.8%
Free cash flow
-$16.0M
Current ratio
2.38×
EPS (diluted)
$-1.32
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| R&D expense | $9.5M | $13.2M | $15.4M | $12.9M | $18.2M |
| SG&A expense | $3.3M | $6.0M |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $5.7M | $20.0M | $19.1M | $18.5M | $31.6M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$9.5M | -$13.6M | -$16.0M | -$12.2M | -$16.0M |
| Investing cash flow | — | $0 |
Get NVCT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NVCT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NVCT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"